ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,477Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 2588

$652K Total Retail Price of All Prescriptions

Rank: 275 out of 2588

181 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 181 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,705 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 547 474 1 1
FUROSEMIDE 491 435 2 5
NAMENDA 358 358 3 32
OMEPRAZOLE 312 300 4 6
GABAPENTIN 301 280 5 18
LEVOTHYROXINE SODIUM 283 271 6 2
DONEPEZIL HCL 276 276 7 22
METOPROLOL TARTRATE 276 266 7 9
LISINOPRIL 275 264 9 3
AMLODIPINE BESYLATE 222 222 10 4
WARFARIN SODIUM 200 192 11 10
HYDROCODONE-ACETAMINOPHEN 192 179 S3 12 7
CITALOPRAM HBR 188 185 13 27
RANITIDINE HCL 182 157 14 37
POLYETHYLENE GLYCOL 3350 174 174 15 55
ESCITALOPRAM OXALATE 168 168 16 68
KLOR-CON M20 158 127 17 52
OXYBUTYNIN CHLORIDE ER 141 130 18 85
RISPERIDONE 137 137 19 57
MIRTAZAPINE 136 124 20 63
GLIPIZIDE 123 123 21 44
POTASSIUM CHLORIDE 121 109 22 15
CARBIDOPA-LEVODOPA 119 119 23 83
METFORMIN HCL 105 105 24 8
SPIRONOLACTONE 103 92 25 58
DIOVAN 96 96 26 29
TAMSULOSIN HCL 95 95 27 23
SERTRALINE HCL 93 93 28 26
PREDNISONE 90 87 29 42
CARVEDILOL 87 78 30 20
DIVALPROEX SODIUM 85 85 31 89
QUETIAPINE FUMARATE 85 68 31 74
FORTICAL 83 83 33 293
METOLAZONE 80 80 34 152
PHENYTOIN SODIUM EXTENDED 78 78 35 109
ATORVASTATIN CALCIUM 76 71 36 11
CLOPIDOGREL 72 66 37 30
HYDROCHLOROTHIAZIDE 71 71 38 13
LANTUS 71 70 38 47
ATENOLOL 70 70 40 14
LIDODERM 69 69 41 86
METOPROLOL SUCCINATE 69 69 41 12
CYMBALTA 69 69 41 70
SEROQUEL 66 56 44 186
DILTIAZEM 24HR CD 65 65 45 98
DIGOXIN 64 54 46 38
PLAVIX 64 59 46 43
FAMOTIDINE 63 63 48 36
LEVOFLOXACIN 63 63 48 77
LEXAPRO 62 62 50 182
IPRATROPIUM-ALBUTEROL 62 61 50 104
NAPROXEN 60 60 52 95
TRAMADOL HCL 60 27 52 19
SODIUM CHLORIDE 59 52 54 168
NOVOLOG 57 57 55 103
TAMIFLU 56 54 56 313
ENULOSE 56 40 56 298
CALCITONIN-SALMON 55 55 58 203
MIDODRINE HCL 53 31 59 365
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.